Related Experiment Videos
Using mRNA expression profiling to determine anticancer drug efficacy
Gerrit Los1, Fei Yang, Goli Samimi
1UCSD Cancer Center, University of California at San Diego, La Jolla, California 92037-0058, USA. glos@ucsd.edu
Abstract:
Pharmacogenomics is a fast-growing field of investigations that aims to further elucidate the inherited nature of interindividual differences in drug disposition and effects, with the ultimate goal of providing a stronger scientific basis for selecting the optimal drug therapy. Providing the right drug for the right patient is an important problem in the treatment of cancer. This is mainly due to the lack of information about the sensitivity of the tumor for a specific treatment modality, such as either chemotherapy or radiation treatment. This presentation highlights two approaches to identify responsiveness to treatment. Both approaches are based on the identification of expression profiles. The first approach concentrates on drug resistance and the second on the signaling pathways leading up to the death of the cell. Both approaches provide expression profiles; however, the more dynamic expression profiling as used to determine the signaling in damage cells promises to be a better determinant for the pharmacogenomic changes in expression profiles and, consequently, a potential better determinant for drug efficacy.
Insights
Pharmacogenomics research identifies inherited differences in drug response to personalize cancer treatment. Dynamic expression profiling of cell signaling pathways shows promise for predicting drug efficacy.
Area of Science:
- Pharmacogenomics
- Cancer Therapeutics
- Molecular Biology
Background:
- Personalized medicine aims to optimize drug selection for individual patients, particularly in cancer treatment.
- Tumor sensitivity to therapies like chemotherapy and radiation is often poorly understood.
- Pharmacogenomics investigates genetic influences on drug disposition and effects to guide therapy.
Purpose of the Study:
- To present two expression profiling approaches for identifying patient responsiveness to cancer treatments.
- To evaluate the potential of these methods in predicting drug efficacy.
Main Methods:
- Two expression profiling strategies were employed to assess treatment responsiveness.
- Approach 1 focused on identifying drug resistance.
- Approach 2 analyzed signaling pathways involved in cell death, utilizing dynamic expression profiling.
Main Results:
- Both approaches generated expression profiles.
- Dynamic expression profiling of damaged cells provided a more detailed view of pharmacogenomic changes.
- This dynamic profiling demonstrated potential as a superior predictor of drug efficacy.
Conclusions:
- Expression profiling is a valuable tool for understanding treatment response in cancer.
- Dynamic expression profiling of cell signaling pathways offers a promising avenue for predicting pharmacogenomic outcomes.
- This approach could significantly enhance the selection of optimal drug therapies for cancer patients.